These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9022296)

  • 1. The effects of in vivo and in vitro non-enzymatic glycosylation and glycoxidation on physico-chemical properties of haemoglobin in control and diabetic patients.
    Watala C; Golański J; Witas H; Gurbiel R; Gwoździński K; Trojanowski Z
    Int J Biochem Cell Biol; 1996 Dec; 28(12):1393-403. PubMed ID: 9022296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus.
    Watala C; Witas H; Olszowska L; Piasecki W
    Int J Exp Pathol; 1992 Oct; 73(5):655-63. PubMed ID: 1329916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patients.
    Pieri C; Testa R; Marra M; Bonfigli AR; Manfrini S; Testa I
    Gerontology; 2001; 47(2):88-92. PubMed ID: 11287733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of improved control on blood filtration properties and non-enzymatic glycosylation of erythrocyte proteins in type 2 diabetes.
    Yue DK; Capogreco C; McLennan SV; Turtle JR
    Diabet Med; 1989 Aug; 6(6):486-9. PubMed ID: 2527128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocytes properties in varicose veins patients.
    Gwozdzinski L; Pieniazek A; Bernasinska J; Grabowski M; Kowalczyk E; Gwozdzinski K
    Microvasc Res; 2017 May; 111():72-79. PubMed ID: 28012884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients.
    Symeonidis A; Athanassiou G; Psiroyannis A; Kyriazopoulou V; Kapatais-Zoumbos K; Missirlis Y; Zoumbos N
    Clin Lab Haematol; 2001 Apr; 23(2):103-9. PubMed ID: 11488849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus.
    Milsom AB; Jones CJ; Goodfellow J; Frenneaux MP; Peters JR; James PE
    Diabetologia; 2002 Nov; 45(11):1515-22. PubMed ID: 12436334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycaemia alters the physico-chemical properties of proteins in erythrocyte membranes of diabetic patients.
    Watala C
    Int J Biochem; 1992 Nov; 24(11):1755-61. PubMed ID: 1333422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diabetic control and biosynthetic human insulin on blood rheology in established diabetics.
    Leiper JM; Lowe GD; Anderson J; Burns P; Cohen HN; Manderson WG; Forbes CD; Barbenel JC; MacCuish AC
    Diabetes Res; 1984 May; 1(1):27-30. PubMed ID: 6397284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of normal and glycated human haemoglobin with erythrocyte membranes from normal and diabetic individuals.
    Bryszewska M
    J Clin Chem Clin Biochem; 1988 Dec; 26(12):809-13. PubMed ID: 3235956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of in vitro carbamylation of erythrocytes on their rheological properties].
    Colin F; Menez JF; Meskar A; Moan M; Le Roux AM; Vicariot M
    Ann Biol Clin (Paris); 1987; 45(5):509-14. PubMed ID: 3425984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
    Delpierre G; Veiga-da-Cunha M; Vertommen D; Buysschaert M; Van Schaftingen E
    Diabetes Metab; 2006 Feb; 32(1):31-9. PubMed ID: 16523184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the HbA1c level of type 2 diabetics on the structure of haemoglobin.
    Ye S; Ruan P; Yong J; Shen H; Liao Z; Dong X
    Sci Rep; 2016 Sep; 6():33352. PubMed ID: 27624402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of spectrin and deformability defects in diabetic erythrocytes.
    Schwartz RS; Madsen JW; Rybicki AC; Nagel RL
    Diabetes; 1991 Jun; 40(6):701-8. PubMed ID: 2040386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct measurement of erythrocyte deformability in diabetes mellitus with a transparent microchannel capillary model and high-speed video camera system.
    Tsukada K; Sekizuka E; Oshio C; Minamitani H
    Microvasc Res; 2001 May; 61(3):231-9. PubMed ID: 11336534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence for the alterations in protein structure and conformation upon in vitro nonenzymatic glycosylation.
    Watala C; Gwozdzinski K; Malek M
    Int J Biochem; 1992 Aug; 24(8):1295-302. PubMed ID: 1322846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of delta-gluconolactone, an oxidised analogue of glucose, on the nonenzymatic glycation of human and rat haemoglobin.
    Lindsay RM; Smith W; Lee WK; Dominiczak MH; Baird JD
    Clin Chim Acta; 1997 Jul; 263(2):239-47. PubMed ID: 9246427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction formula for carbamylated haemoglobin in diabetic uraemic patients.
    Hammouda AM; Mady GE
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):115-9. PubMed ID: 11269750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the conformational state of hemoglobin in hemodialysed patients with chronic renal failure.
    Pieniazek A; Gwozdzinski K
    Oxid Med Cell Longev; 2015; 2015():783073. PubMed ID: 25866600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic control in type 2 diabetics and the mean corpuscular fragility.
    Ibanga IA; Usoro CA; Nsonwu AC
    Niger J Med; 2005; 14(3):304-6. PubMed ID: 16350703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.